Aclarion, Inc. (NASDAQ:ACON – Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 122,800 shares, a drop of 73.9% from the February 28th total of 471,200 shares. Currently, 24.3% of the company’s shares are short sold. Based on an average daily volume of 4,910,000 shares, the short-interest ratio is currently 0.0 days.
Aclarion Stock Performance
Shares of Aclarion stock opened at $0.52 on Friday. The business has a 50-day moving average of $2.91 and a 200 day moving average of $35.94. Aclarion has a 12 month low of $13.10 and a 12 month high of $6,241.05.
Wall Street Analysts Forecast Growth
Separately, Maxim Group restated a “hold” rating on shares of Aclarion in a research note on Friday, December 13th.
About Aclarion
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Read More
- Five stocks we like better than Aclarion
- Short Selling – The Pros and Cons
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Top 3 Beverage Stocks Pouring Out Profits
- What is the Nikkei 225 index?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
